Table 3 Hazard ratios (95% CI) for liver cancer mortality according to depressive symptoms by HBsAg positivity (n = 342,998).
CES-D score category | Person-years | Number of events | Mortality rate (per 105 person-years) | Age-sex adjusted HR (95% CI) | Multivariable-adjusted HR† (95% CI) | HR (95% CI) ‡ in model using time-dependent variables | |
|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | ||||||
Total | |||||||
< 16 | 1,613,583.7 | 44 | 2.7 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
≥ 16 | 222,924.8 | 10 | 4.5 | 2.18 (1.09–4.36) | 2.07 (1.03–4.18) | 2.19 (1.08–4.42) | 1.88 (0.90–3.93) |
HBsAg (−) | |||||||
< 16 | 1,559,740.4 | 23 | 1.5 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
≥ 16 | 216,366.8 | 3 | 1.4 | 1.22 (0.37–4.09) | 1.11 (0.33–3.71) | 1.08 (0.32–3.62) | 0.91 (0.27–3.05) |
HBsAg (+) | |||||||
< 16 | 53,843.2 | 21 | 39.0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
≥ 16 | 6,558.0 | 7 | 106.7 | 3.22 (1.36–7.67) | 3.31 (1.37–7.97) | 3.82 (1.57–9.25) | 3.83 (1.47–9.98) |